Patents Assigned to Elgan Pharma Ltd
  • Insulin formulations and methods of using same in preterm infants
    Patent number: 11883467
    Abstract: An insulin formulation and a method of preparing and using same. The insulin preparation includes insulin, oligosaccharide and sodium chloride at a ratio of 1:A:B (w:w:w respectively) with ranges of A and B are 1000-5000 and 10-50, respectively.
    Type: Grant
    Filed: September 6, 2022
    Date of Patent: January 30, 2024
    Assignee: Elgan Pharma Ltd
    Inventors: Michal Olshansky, Elena Ostrovsky, Stav Zeldis
  • MULTIPARTICULATE GRANULATE COMPRISING INSULIN
    Publication number: 20230181695
    Abstract: The present invention is directed to multiparticulate granulate compositions comprising particles of insulin and particles of an infant nutritional excipient, wherein the multiparticulate granulate is substantially free of layers of insulin and excipient, methods of making thereof, and methods of use thereof.
    Type: Application
    Filed: November 24, 2022
    Publication date: June 15, 2023
    Applicant: Elgan Pharma Ltd
    Inventor: Roman SAFONOV
  • INSULIN FORMULATIONS AND METHODS OF USING SAME IN PRETERM INFANTS
    Publication number: 20230000953
    Abstract: An insulin formulation and a method of preparing and using same. The insulin preparation includes insulin, oligosaccharide and sodium chloride at a ratio of 1:A:B (w:w:w respectively) with ranges of A and B are 1000-5000 and 10-50, respectively.
    Type: Application
    Filed: September 6, 2022
    Publication date: January 5, 2023
    Applicant: Elgan Pharma Ltd
    Inventors: Michal OLSHANSKY, Elena OSTROVSKY, Stav ZELDIS
  • COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY
    Publication number: 20220226443
    Abstract: A pharmaceutical composition including insulin, Docosahexaenoic acid (DHA) and coenzyme Q10 and methods of manufacturing and using the composition are provided.
    Type: Application
    Filed: May 27, 2020
    Publication date: July 21, 2022
    Applicant: Elgan Pharma Ltd
    Inventors: Michal OLSHANSKY, Elena OSTROVSKY, Stav ZELDIS
  • Oxytocin compositions and methods of use
    Patent number: 11266711
    Abstract: Disclosed are oxytocin compositions having a therapeutically effective amount of oxytocin, an analog or derivative of oxytocin, or an oxytocin receptor agonist for the treatment of neonatal abstinence syndrome (“NAS”) in a subject. Also disclosed are methods for the treatment of NAS by administering a therapeutically effective amount of oxytocin, an analog or derivative of oxytocin, or an oxytocin receptor agonist to a subject.
    Type: Grant
    Filed: April 8, 2019
    Date of Patent: March 8, 2022
    Assignee: Elgan Pharma Ltd
    Inventors: Dean S. Carson, Marc Pentopoulos